Category Archives: News

Genetic research is enabling the development of therapies for certain ALS patients. Treatments such as tofersen have shown that identifying certain genetic alterations can have direct therapeutic implications.   24.06.2026   Amyotrophic lateral sclerosis is a complex disease. Approximately 90% of cases are not inherited, and the exact cause of the disease is unknown. However, […]

Long-read RNA sequencing allows the identification of tumor alterations that may go undetected with conventional methods. Health in Code is the first company to develop this technology in Spain thanks to a project funded by IVACE+i with European funds.   21.05.2026   Many cancer treatments today depend on identifying very specific genetic alterations in tumors. […]

Our identity evolves to reflect who we are and where we want to keep moving forward: a company built on healthcare data, technology, and real impact on people’s lives.   20.05.2026   We haven’t changed what we are. We’ve changed how we show it.   In genetics, DNA is preserved. What changes is its expression: […]

An analysis of outcomes from a cohort of 1,261 patients from the prospective FLEX study has shown that women with HR+/HER2- early-stage breast cancer who benefit the most from anthracycline-based chemotherapy are those with tumors classified as MammaPrint High Risk 2 and BluePrint Luminal B.     February 12, 2026.    Anthracycline-based chemotherapy is considered […]

A new targeted therapy for metastatic castration-resistant prostate cancer (mCRPC), Akeega®, is already funded and available in Spain after approval of pricing and reimbursement by the National Healthcare System. This step constitutes a significant advance in the approach to this pathology and highlights the key role of molecular diagnosis in clinical practice.     January […]

October 24, 2025.    At the Health in Code Group, we understand that our commitment to sustainability is not merely an add-on, but a cross-cutting way of working and serving the health of people and the planet.   In our new 2024 Sustainability Report, we present in a highly detailed and transparent way our latest […]

Proteomics is the branch of biology that studies the complete set of proteins produced by an organism, tissue, cell, or biological system at a given moment. The proteomics offered by Olink enables secretome analysis by combining high sensitivity, specificity, and scalability, making it especially valuable in biomedicine, oncology, immunology, and complex diseases. Olink has accredited […]

We have obtained ISO 45001 certification, which recognizes our effectiveness in caring for our team and work environment. This recognition confirms that an organization manages occupational health and safety (OHS) effectively through a structured, proactive system based on continuous improvement.   Madrid, June 30, 2025.   Health in Code has reached a new milestone in […]